Results 31 to 40 of about 16,993 (221)

The role of the host—Neutrophil biology

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple   +4 more
wiley   +1 more source

Ex vivo treatment of peripheral blood mononuclear cells (PBMC) with L-sulforaphane

open access: yes, 2022
Blood samples were collected from healthy volunteers, PBMC were collected using standard ficoll centrifugation. RNA was collected from untreated and PBMC treated with 15 µM L-sulforaphane for 24 hours.
Tom Karagiannis (12036224)   +2 more
core   +1 more source

Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS

open access: yesAMB Express, 2020
Sulforaphane (SFN) is a kind of natural isothiocyanate, which exists in cruciferous plants. Only few studies were about the anti-inflammatory effects of sulforaphane in ulcerative colitis.
Yan Zhang   +5 more
doaj   +1 more source

Efficacy of Sulforaphane in Neurodegenerative Diseases [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Sulforaphane (SFN) is a phytocompound belonging to the isothiocyanate family. Although it was also found in seeds and mature plants, SFN is mainly present in sprouts of many cruciferous vegetables, including cabbage, broccoli, cauliflower, and Brussels sprouts.
Schepici, Giovanni   +2 more
openaire   +2 more sources

Sulforaphanes: disruptors of phagophores and autolysosomes

open access: yesAutophagy Reports, 2022
Sulforaphane and its metabolites (SFNs) cause apoptosis in cancers and could be potential anti-cancer drugs. We focused on investigating the underlying mechanisms through which SFNs inhibit cancers. First, SFNs cause microtubule disruption by phosphorylated MAPK1/ERK2-MAPK3/ERK1-mediated activation of 26S proteasome leading to a microtubule-associated ...
Yan Zhou, Wei Wu
openaire   +3 more sources

Monitoring Keap1-Nrf2 interactions in single live cells [PDF]

open access: yes, 2014
The transcription factor NF-E2 p45-related factor 2 (Nrf2) and its negative regulator Kelch-like ECH associated protein 1 (Keap1) control the expression of nearly 500 genes with diverse cytoprotective functions.
Dinkova-Kostova, Albena, T   +4 more
core   +1 more source

Use of sulforaphane in COVID-19:Clinical trials are needed

open access: yes, 2022
We read with interest the narrative review authored by Kiser et al. (2021), which discussed extensively the antioxidant effect and anti-inflammatory effect of sulforaphane, a dietary supplement found in high amounts in cruciferous vegetables that is ...
Ramachandram, Dinesh Sangarran   +5 more
core   +1 more source

The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.

open access: yesPLoS ONE, 2021
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is an important transcription factor that plays a pivotal role in cellular defense against oxidative injury.
Su-Jin Moon   +7 more
doaj   +1 more source

Anticancer activity of sulforaphane against human hepatoblastoma cells involves apoptosis, autophagy and inhibition of β-catenin signaling pathway

open access: yes, 2020
Introduction Sulforaphane is an active isothiocyanate and has been reported to exhibit many pharmacological and biological activities including anticancer activity.
Junshan Lin   +3 more
core   +1 more source

Sulforaphane reduces obesity by reversing leptin resistance. [PDF]

open access: yes, 2022
The ascending prevalence of obesity in recent decades is commonly associated with soaring morbidity and mortality rates, resulting in increased health-care costs and decreased quality of life.
Fadel, Amina   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy